BDX vs MDT
Becton Dickinson & Co. and Medtronic PLC, side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | BDX | MDT |
|---|---|---|
| Revenue | $21.8B | $36.4B |
| Net income | $1.7B | $4.8B |
| Gross margin | 45.4% | 65.0% |
| Net margin | 7.7% | 13.2% |
| Return on equity | 6.5% | 9.8% |
| Diluted EPS | $5.82 | $3.73 |
| Dividend / share | $4.16 | $2.84 |
| Payout ratio | 71.3% | 75.8% |
| Free cash flow | $2.7B | $5.4B |
| Equity | $25.4B | $49.5B |
| Net debt / equity | 0.73× | 0.53× |
| Current ratio | 1.11× | 2.13× |
| Revenue CAGR 5y | 6.3% | 3.8% |
| Profit CAGR 5y | 13.9% | 5.9% |
MDT bills 1.7× the revenue of BDX, and keeps more of each dollar of revenue as profit (13.2% against 7.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Advertisement
AdSense · Leaderboard 728×90 · responsive
Revenue by year
10 years side by side
| Fiscal year | BDX | MDT |
|---|---|---|
| FY2025 | $21.8B | $36.4B |
| FY2024 | $20.2B | $33.5B |
| FY2023 | $19.4B | $32.4B |
| FY2022 | $18.9B | $31.2B |
| FY2021 | $19.1B | $31.7B |
| FY2020 | $16.1B | $30.1B |
| FY2019 | $17.3B | $28.9B |
| FY2018 | $16.0B | $30.6B |
| FY2017 | $12.1B | $30.0B |
| FY2016 | $12.5B | $29.7B |
Net income by year
Bottom line
| Fiscal year | BDX | MDT |
|---|---|---|
| FY2025 | $1.7B | $4.8B |
| FY2024 | $1.7B | $4.7B |
| FY2023 | $1.5B | $3.7B |
| FY2022 | $1.8B | $3.8B |
| FY2021 | $2.1B | $5.0B |
| FY2020 | $874.0M | $3.6B |
| FY2019 | $1.2B | $4.8B |
| FY2018 | $311.0M | $4.6B |
| FY2017 | $1.1B | $3.1B |
| FY2016 | $976.0M | $4.0B |
Advertisement
AdSense · Rectangle 336×280